Concentra Group (CON) is a Great Momentum Stock: Should You Buy?
Concentra Group (CON) is highlighted as a strong momentum stock, warranting investor attention. The article discusses Concentra's impressive price performance over various periods, outperforming both its industry and the S&P 500. Furthermore, positive earnings estimate revisions and a Zacks Rank of #2 (Buy) contribute to its favorable outlook.
Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health
Concentra announced the appointment of Dr. Jill Rosenthal as Chief Medical Officer, effective January 1, 2027. Dr. Rosenthal, a nationally recognized occupational medicine leader and current president of ACOEM, will lead Concentra's clinical strategy, innovation, and quality initiatives. She succeeds Dr. John Anderson and aims to strengthen Concentra's position as a leading occupational health provider.
How Investors Are Reacting To Concentra Group Holdings Parent (CON) Earnings Beat, Guidance Hike And CEO Transition
Concentra Group Holdings Parent (CON) reported strong Q2 2026 results, beating sales and net income expectations, and subsequently raised its full-year 2026 earnings guidance. The company also announced a planned CEO transition effective November 1, 2026, and declared a dividend, signaling operational momentum and governance continuity. This positive news supports Concentra's investment narrative, although some analysts remain cautious about long-term growth sustainability.
How Investors Are Reacting To Concentra Group Holdings Parent (CON) Earnings Beat, Guidance Hike And CEO Transition
Concentra Group Holdings Parent, Inc. (CON) reported strong second-quarter 2026 results, beating earnings expectations and raising its full-year guidance for both revenue and net income. The company also announced a planned CEO transition and continues its share repurchase program and dividend distribution. These developments reinforce Concentra's operational momentum and governance continuity, contributing to a positive investment narrative despite potential risks related to visit growth and reimbursement trends.
Concentra Group Holdings Parent Inc stock hits all-time high at 35.16 USD
Concentra Group Holdings Parent Inc. stock has reached an all-time high of $35.16, contributing to a market capitalization of $4.48 billion and marking a 79% year-to-date return. Despite its overvalued status according to InvestingPro, the company demonstrates strong financial health with a Piotroski Score of 9. This performance follows a robust second quarter, with revenue increasing by 10% to $606 million and adjusted EPS of $0.52, leading to raised full-year financial guidance.
Concentra Group Holdings Parent (NYSE:CON) Sets New 1-Year High - Here's Why
Concentra Group Holdings Parent (NYSE:CON) has reached a new 52-week high of $35.33, driven by positive analyst sentiment and strong financial performance. The company surpassed quarterly earnings expectations with an EPS of $0.52 and revenue of $606.03 million, marking a 10% year-over-year increase. Despite some insider selling, institutional investors have increased their stakes, and analysts maintain a "Moderate Buy" rating with a consensus target price of $37.00.
BofA Securities Adjusts Concentra Group Price Target to $40 From $36
BofA Securities has increased its price target for Concentra Group to $40 from the previous $36. The firm maintains a Neutral rating on the company's stock. This adjustment reflects a revised outlook on Concentra Group by BofA Securities.
BofA Securities Adjusts Price Target on Concentra Group to $40 From $36
BofA Securities has raised its price target for Concentra Group Holdings Parent, Inc. (CON) to $40 from $36, as reported by MT Newswires.
Analysts Offer Insights on NA Companies: Rapid7 (RPD) and Concentra Group Holdings Parent, Inc. (CON)
Analysts from BTIG and Wells Fargo have provided insights on Rapid7 (RPD) and Concentra Group Holdings Parent, Inc. (CON). BTIG maintained a Hold rating for Rapid7, while Wells Fargo assigned a Buy rating to Concentra, indicating potential upside. This report summarizes recent analyst actions and price targets for both companies.
Concentra Group Holdings Parent, Inc. Just Recorded A 25% EPS Beat: Here's What Analysts Are Forecasting Next
Concentra Group Holdings Parent, Inc. (NYSE:CON) recently reported its Q2 results, surpassing revenue and EPS estimates. Analysts have updated their forecasts, showing increased optimism for the company's earnings potential, leading to a 6.0% rise in the consensus price target. While revenue growth is expected to slow compared to historical rates, it is projected to remain in line with industry growth estimates.
Concentra Group Holdings Parent, Inc. Stock 12‑Month Price Target Raised to $39.12, Implies 18% Upside
The average 12-month price target for Concentra Group Holdings Parent, Inc. stock has been raised from $38.62 to $39.12 by 8 analysts, with a range of $34 to $42. This new target implies an 18% potential upside based on the Aug. 11 closing price. The consensus rating from 9 covering analysts remains "Buy," with no "Holds" or "Sells."
Concentra Group Holdings Parent (CON) Is Up 7.6% After Raising 2026 Guidance And Detailing CEO Succession – Has The Bull Case Changed?
Concentra Group Holdings Parent (CON) recently announced strong Q2 2026 results, raising full-year 2026 guidance and reaffirming its quarterly dividend. The company also detailed a CEO succession plan, with Matt DiCanio set to take over in November 2026, while current CEO Keith Newton will become executive chairman. These developments are viewed positively, reinforcing the company's growth story and capital return program, though high leverage remains a key consideration for investors.
Concentra Group Holdings Parent (CON) Is Up 7.6% After Raising 2026 Guidance And Detailing CEO Succession – Has The Bull Case Changed?
Concentra Group Holdings Parent (CON) recently reported strong Q2 2026 results, raising full-year guidance and reaffirming its dividend. The company also announced a CEO succession plan, with current President and CFO Matt DiCanio set to take over in November 2026. This positive news, coupled with continued stock buybacks, has led to a 7.6% stock increase, though investors should consider the company's high leverage and valuation relative to consensus targets.
Concentra Group Holdings Parent, Inc. (CON) Hit a 52 Week High, Can the Run Continue?
Concentra Group Holdings Parent, Inc. (CON) recently hit a 52-week high of $35.15, with shares up 8% over the past month and 73.1% year-to-date. This outperformance is driven by a strong record of positive earnings surprises, with the company beating consensus estimates in the last four quarters. Despite trading at a premium compared to its peers, Concentra holds a Zacks Rank of #2 (Buy) and strong Style Scores for Growth and Momentum, suggesting potential for continued growth.
Concentra Group Holdings Parent, Inc. Just Recorded A 25% EPS Beat: Here's What Analysts Are Forecasting Next
Concentra Group Holdings Parent, Inc. (NYSE:CON) reported strong second-quarter results, exceeding revenue and EPS expectations. Analysts have increased their earnings per share estimates and raised the consensus price target to US$35.38, indicating increased optimism. Despite a projected slowdown in revenue growth, it is expected to align with the industry average.
CONCENTRA GROUP HOLDINGS PARENT INC : RBC RAISES TARGET PRICE TO $42 FROM $36
RBC has increased its target price for CONCENTRA GROUP HOLDINGS PARENT INC (CON.N) to $42 from the previous $36. This updated target reflects an optimistic outlook from RBC regarding the company's future performance.
Concentra Group Holdings Parent (CON) Is Up 7.6% After Raising 2026 Outlook And Announcing CEO Transition
Concentra Group Holdings Parent (CON) saw its stock rise 7.6% after reporting Q2 2026 results, raising its full-year 2026 outlook, affirming a dividend, and announcing a CEO transition effective November 1, 2026. The company now expects revenues between US$2.325 billion and US$2.375 billion and net income between US$210 million and US$217 million. Despite the positive outlook, the article highlights the continued risk of elevated leverage for the company.
Concentra Group Holdings Parent, Inc. Stock 12‑Month Price Target Raised to $34.62, Implies 13% Upside
The average 12-month price target for Concentra Group Holdings Parent, Inc. (CON) stock has been raised to $34.62, up from $33.38, according to estimates from 8 analysts. This updated target implies a 13% potential upside based on the Aug. 6 closing price, with forecasts ranging from $28 to $40 per share. The consensus rating among 9 covering analysts remains "Buy," with no Hold or Sell recommendations.
Concentra Group Holdings Parent (NYSE:CON) Reaches New 12-Month High After Earnings Beat
Concentra Group Holdings Parent (NYSE:CON) hit a new 52-week high after reporting better-than-expected quarterly earnings, with EPS of $0.52 against a $0.42 consensus and revenue of $606.03 million, up 10% year-over-year. Analysts remain largely positive, with seven rating the stock a "Buy" and one a "Hold," and Truist raising its price target to $37. The company also declared a quarterly dividend of $0.0625 per share, though insiders have sold a significant number of shares recently.
Earnings call transcript: Concentra Q2 2026 profit, guidance raise lift shares 11%
Concentra Group Holdings Parent Inc. reported strong Q2 2026 results with a 10% increase in revenue to $606 million and adjusted EPS of $0.52, leading to an 11% surge in shares. The company also raised its full-year 2026 guidance for revenue, adjusted EBITDA, and free cash flow, attributing the success to higher visit volume, stronger pricing, market share gains, and technology upgrades. CEO Keith Newton announced his transition to Executive Chairman, with President and CFO Matt DiCanio set to take over as CEO, assuring continuity in strategy.
Earnings Flash (CON) Concentra Group Holdings Parent, Inc. Posts Q2 Adjusted EPS $0.52 per Share, Vs. FactSet Est of $0.42
Concentra Group Holdings Parent, Inc. (CON) announced its Q2 adjusted EPS of $0.52 per share, exceeding the FactSet estimate of $0.42 per share. This indicates a stronger financial performance than anticipated by analysts for the quarter.
Concentra Group Holdings Parent, Inc. (CON) Stock Price, News, Quote & History
This Yahoo Finance page provides comprehensive information on Concentra Group Holdings Parent, Inc. (CON) stock, including its current price, historical data, financial overview, and analyst insights. The stock closed at $34.06 on August 7, 2026, up 11.53%, with significant year-to-date and one-year returns. The company, which offers occupational health services, reported Q1 FY26 revenue of $569.55M and earnings of $50.49M.
CON: Q2 2026 delivered robust revenue and EBITDA growth, with raised full-year guidance and lower leverage
Concentra Group Holdings (CON) reported strong Q2 2026 results, showing double-digit revenue and Adjusted EBITDA growth, along with margin expansion and increased volumes in core services. The company also raised its full-year guidance for revenue, EBITDA, and free cash flow, achieving its leverage targets earlier than expected.
Concentra Q2 2026 earnings: Operating leverage lifts profit and cash flow
Concentra (NYSE: CON) reported a strong Q2 2026, with revenue up 10.0% to $606.0 million and diluted EPS rising to $0.51 from $0.35. The company benefited from operating leverage, as costs grew slower than revenue, leading to a 46.5% increase in net income and a significant boost in free cash flow by 91.6%. Concentra also raised its full-year 2026 guidance and announced a planned leadership transition.
Earnings Flash (CON) Concentra Group Holdings Parent, Inc. Posts Q2 Adjusted EPS $0.52 per Share, vs. FactSet Est of $0.42
Concentra Group Holdings Parent, Inc. reported Q2 adjusted EPS of $0.52 per share, surpassing the FactSet estimate of $0.42. The company also announced an increase in its 2026 revenue guidance, board changes, and the appointment of Matt DiCanio as CEO.
Concentra Group Holdings Parent Inc (CON) Q2 2026 Earnings Report Preview: What To Expect
Concentra Group Holdings Parent Inc (CON) is scheduled to release its Q2
Concentra Group Holdings Parent, Inc. (NYSE: CON) director sells 130,000 shares
Concentra Group Holdings Parent, Inc. (NYSE: CON) director Robert A. Ortenzio sold 130,000 shares of common stock on August 3, 2026, at a weighted average price of $31.8412 per share. The sale, valued at $4.14 million, was executed indirectly through The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio as part of a pre-arranged trading plan. Post-transaction, Ortenzio maintains significant direct and indirect holdings in the company.
Concentra Group Holdings Parent, Inc. 2026: Revenue $606.03M, EPS $0.51— 10-Q Summary
Concentra Group Holdings Parent, Inc. reported strong financial results for the 2026 quarter, with revenue reaching $606.03 million and diluted earnings per share at $0.51. This represents a 10% year-over-year revenue growth and a 45.7% increase in diluted EPS, driven by higher patient visits, a shift towards onsite clinics, and improved operational efficiency. The company expanded its network to 633 centers and 415 onsite clinics and reduced its cost of services.
Concentra Group Holdings Parent, Inc. (NYSE:CON) Given Average Rating of "Moderate Buy" by Brokerages
Concentra Group Holdings Parent, Inc. (NYSE:CON) has received an average "Moderate Buy" rating from eight brokerages, with an average 12-month price target of $31.40. The company recently exceeded earnings expectations, reporting EPS of $0.40 against an estimated $0.35, and revenue of $569.55 million, a 13.7% year-over-year increase. Despite strong stock performance and a share price near its 52-week high, insider selling has been observed, with Director Robert A. Ortenzio selling 130,000 shares for approximately $4.0 million.
Concentra Group Holdings Parent (CON) Stock Analysis: Robust Growth and Strong Buy Ratings Fuel Investor Optimism
Concentra Group Holdings Parent (CON) is showing strong growth in the healthcare sector, with a robust revenue increase of 13.70% and an impressive return on equity of 47.00%. The company's stock, currently at $31.70, has a positive outlook from analysts, with nine buy ratings and an average price target suggesting a 5.28% upside. Despite some technical indicators suggesting the stock is overbought in the short term, its strong financial fundamentals and strategic positioning in occupational health make it an attractive investment.
CONMED (CON) trusts detail 130,000-share planned sale and recent large stock trades
CONMED Corporation's affiliated trusts have filed a Form 144 for the potential sale of 130,000 common shares through UBS Financial Services Inc., with an aggregate market value of $4,114,500. This planned sale represents a small fraction of the 127,961,780 shares outstanding as of August 3, 2026. The filing also details several large past sales by The Rocco A Ortenzio Trust FBO Robert Ortenzio and The Revocable Trust of Rocco A Ortenzio, including blocks up to 259,940 shares.
Form 144 Concentra Group Holdings Parent For: 3 August By Investing.com
This article announces a Form 144 filing by Concentra Group Holdings Parent for August 3rd. It is a brief, one-line report from Investing.com, providing no additional details or context about the filing. The article also includes a stock market snapshot with various indices and commodity prices.
Concentra Group Holdings Parent Inc (CON) Financial Health: Profitability & Balance Sheet Analysis
Concentra Group Holdings Parent Inc (CON) has a current financial score of 8.02, ranking 28 out of 75 in the Healthcare Providers & Services industry, indicating a weak financial status but high operating efficiency. The company's latest quarterly revenue was $569.55 million, a 13.74% year-over-year increase, with net profit rising 28.52% year-over-year. While some data on financial aspects like cash and assets are pending disclosure, the company shows strong growth potential and shareholder returns.
BlackRock (CON) discloses 13.7% Concentra stake with sole voting control
BlackRock, Inc. has filed a Schedule 13G/A, disclosing a 13.7% beneficial ownership stake in Concentra Group Holdings Parent Inc. The filing indicates BlackRock holds sole voting power over 17,378,159 shares and sole dispositive power over 17,569,590 shares, with no shared powers. An iShares ETF associated with BlackRock also holds an interest exceeding five percent of Concentra's common stock.
CON|Concentra Group Holdings Parent Inc|Price:31.910|Chg%:+0.300
This article provides a detailed company profile for Concentra Group Holdings Parent, Inc. (CON), an occupational health services provider in the United States. It outlines the company's business scope, including its various segments like Occupational Health Centers and Onsite Health Clinics, and provides key financial data, market performance indicators, executive details, and shareholder information. The company serves over 50,000 patients daily across 620 centers in 41 states and 160 onsite clinics in 36 states.
Concentra Group Holdings Parent, Inc. Revenue Breakdown – NYSE:CON
Concentra Group Holdings Parent, Inc. (NYSE: CON) generated $2.16 billion in revenue last year. The largest portion, $1.31 billion, came from its Occupational Health Centers - Workers Compensation segment. All of the company's revenue ($2.16 billion) originated from operations within the United States.
Concentra Group Holdings Parent Q2 2026 Earnings Report
This article provides details about Concentra Group Holdings Parent's upcoming Q2 2026 earnings report, scheduled for August 6, 2026, after market close, with a conference call on August 7, 2026. It includes current stock performance, estimated EPS and revenue, and recent company news, such as a "Buy" rating from Goldman Sachs and expansion efforts. The company, NYSE:CON, is a Canada-based financial services holding company specializing in serving Canadian credit unions.
Concentra Group Holdings Parent Inc (CON) Cash Flow
This article provides a detailed historical overview of Concentra Group Holdings Parent Inc.'s (CON) cash flow statements, including operating, investing, and financing activities. It presents quarterly and annual financial data, highlighting key metrics like net income, capital expenditures, and free cash flow. The article also includes an FAQ section explaining common cash flow terms and CON's specific figures for recent periods.
Concentra Group Holdings Parent Inc (CON) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides historical dividend payout information for Concentra Group Holdings Parent Inc (CON), detailing interim cash dividends distributed over the past five years. The company has consistently paid a gross dividend of USD 0.0625 per share across multiple quarters. The article lists specific record dates, payment dates, and ex-dividend dates for future dividends extending into 2026.
Concentra Group Holdings Parent Inc (CON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article details the revenue breakdown for Concentra Group Holdings Parent Inc (CON) across various business segments and fiscal periods. The primary revenue sources include occupational health centers (workers' compensation and employer services), onsite clinics, and other related services. The data indicates that workers' compensation is the largest contributor to the company's revenue.
CON|Concentra Group Holdings Parent Inc|Price:31.610|Chg%:+0.080
This article provides a detailed financial overview of Concentra Group Holdings Parent Inc. (CON), including quarterly and annual financial statements, key financial indicators like EPS, revenue, net profit, and margins, as well as an analyst rating. It also includes frequently asked questions about the company's financial performance based on its FY2025 earnings report.
Concentra Group Holdings Parent Inc (CON) Earnings Forecast: Future EPS & Revenue Growth Estimates
Concentra Group Holdings Parent Inc (CON) has an earnings forecast score of 8.29, ranking 21st in the Healthcare Providers & Services industry. Analysts project an average price target of $28.50, with a consensus toward a "Buy" rating. The company's next quarter revenue is expected to be $591.67 million, and EPS for the upcoming quarter is forecast at $0.42.
CON|Concentra Group Holdings Parent Inc|Price:31.610|Chg%:+0.080
Concentra Group Holdings Parent Inc. (CON) shows stable fundamentals and high growth potential, with its valuation considered fairly valued. Institutional ownership is notably high, and analysts currently rate it as a "Buy" with a target price of $33.286. Despite average stock market performance recently, the company's strong fundamentals suggest an upward trend in the medium term, making it suitable for range-bound swing trading.
Concentra Group Holdings stock hits all-time high at 32.38 USD
Concentra Group Holdings' stock has reached an all-time high of $32.38, reflecting a 63.68% increase over the past year. Despite its strong financial health and perfect Piotroski Score, InvestingPro analysis suggests the stock may be overvalued. The company continues its strategic expansion, opening new medical centers and receiving favorable analyst ratings from William Blair and Goldman Sachs.
Concentra Group Holdings stock hits all-time high at 32.38 USD
Concentra Group Holdings' stock has reached an all-time high of $32.38 USD, demonstrating a 63.68% increase over the past year. Despite this growth, InvestingPro analysis suggests the stock may be overvalued relative to its Fair Value. The company continues to expand with new medical center openings and has received favorable analyst ratings from William Blair and Goldman Sachs.
Concentra’s Boise center will offer work injury care and drug testing
Concentra, a national leader in occupational and workforce health services, is opening its first Idaho medical center in Boise on July 22. This expansion aims to provide comprehensive workforce health solutions, including work injury care, drug testing, and physical exams, to employers and employees in the growing Treasure Valley region. The new facility reflects Concentra's confidence in Boise's economy and its commitment to supporting a healthy and productive workforce.
Is Concentra (CON) Using Targeted Clinic Openings to Validate Its Integrated Telemed Strategy?
Concentra Group Holdings Parent recently expanded its services by opening a new medical center near Kansas City International Airport, integrating on-site care with its Concentra Telemed platform. This move supports the company's strategy of combining clinic capabilities with telemedicine to enhance employer convenience and care continuity. The expansion aligns with Concentra's updated 2026 guidance, which accounts for continued new clinic openings and Telemed adoption, though investors should also consider the company's leverage and integration costs.
Concentra Group Holdings Parent, Inc. (CON) Gets a Buy from Goldman Sachs
Goldman Sachs analyst Scott Fidel maintained a Buy rating on Concentra Group Holdings Parent, Inc. (CON) with a $34.00 price target. The analyst consensus for CON is a Strong Buy with an average price target of $33.57, indicating an 8.64% upside. Despite positive analyst ratings and strong quarterly revenue growth, corporate insider sentiment for CON is negative, with an increase in insider selling.
Concentra Group Holdings Parent, Inc. (CON) Gets a Buy from Goldman Sachs
Goldman Sachs analyst Scott Fidel maintained a Buy rating on Concentra Group Holdings Parent, Inc. (CON) with a price target of $34.00, citing the company's strong financial performance with quarterly revenue of $569.56 million and a net profit of $50.49 million. The analyst consensus for CON is a Strong Buy with an average price target of $33.57. Despite this positive outlook, corporate insider sentiment for the stock is negative due to increased selling activity, including a recent sale of 130,000 shares by director Robert Ortenzio.
Analysts Are Bullish on Top NA Stocks: Merlin (MRLN), Concentra Group Holdings Parent, Inc. (CON)
Analysts are maintaining a bullish stance on Merlin (MRLN) and Concentra Group Holdings Parent, Inc. (CON), key players in the北美 sector. Cantor Fitzgerald initiated coverage on Merlin with a Buy rating and a price target of $11.50, while Mizuho Securities maintained a Buy rating on Concentra with a target of $35.00. Both companies, according to TipRanks, have a Strong Buy consensus rating from analysts, indicating positive outlooks for significant upside.
